Ivermectin B1a monosaccharide

Ivermectin B1a monosaccharide

• CAS Number: 71837-27-9
• UNSPSC Description: Ivermectin B1a monosaccharide is a modified Ivermectin B1a (HY-126937). Ivermectin B1a monosaccharide is an antiparasite agent with a minimum concentration for full activity in Haemonchus contortus larval development of 0.001 μg/mL[1].
• Target Antigen: Parasite
• Type: Natural Products
• Related Pathways: Anti-infection
• Applications: COVID-19-immunoregulation
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/ivermectin-b1a-monosaccharide.html
• Solubility: 10 mM in DMSO
• Smiles: O[C@]1([C@@]2([H])C=C(C)[C@H]3O)[C@]3([H])OC/C1=C\C=C\[C@@H]([C@@H](/C(C)=C/C[C@]4([H])C[C@](C[C@@]5(O[C@]([C@@H](C)CC5)([H])[C@@H](C)CC)O4)([H])OC2=O)O[C@@]6([H])C[C@@H]([C@@H](O)[C@H](C)O6)OC)C
• Molecular Weight: 730.92
• References & Citations: [1]Michael B,et al., Comparison of ivermectin, doramectin, selamectin, and eleven intermediates in a nematode larval development assay[J]. Journal of Parasitology, 2001, 87(3): 692-696.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported